Exploring the binding interaction of calf thymus DNA with lapatinib, a tyrosine kinase inhibitor: multi-spectroscopic techniques combined with molecular docking
Journal of Biomolecular Structure and Dynamics. 37:576-583
ISSN:
1538-0254 0739-1102
DOI:
10.1080/07391102.2018.1433067
Popis:
Lapatinib, a double-target receptor tyrosine kinase inhibitor, is an oral-targeted anticancer drug developed by GlaxoSmithKline (GSK). It mainly acts on epidermal growth factor receptor 1 (EGFR1) a...